A non-inferiority randomized trial testing an advice of modeA non-inferiority randomized trial testing an advice of moderate drinking pattern versus advice on abstention on major disease and mortality

ERC (European Research Council)HORIZON-ERCID: 101097681
EC Contribution
€24,985
Consortium Size
1 orgs
Start Year
2023
Summary

Europeans are the largest alcohol consumers. Policymakers and clinicians are currently perplexed on how to reduce alcohol harms in drinkers, due to contradictory guidelines: abstention is proposed as the healthiest option by many health advocates, stating that there is no safe level of alcohol intake; but most nonrandomized studies found lower all-cause mortality and other outcomes in moderate drinkers than in abstainers among subjects >50 years. However, potential biases may compromise these latter studies, particularly when effects are null or moderate. A large pragmatic randomized controlled trial (RCT) of realistic advice aimed to change behavior addressing clinical endpoints is long overdue. It will provide first-level evidence to confront the harms of one of the most widely used substances by humankind. Business issues and conflicts of interests are also at stake. We propose a 4-year non-inferiority RCT with >10,000 drinkers (men 50-70 years or women 55-70 years consuming >=3 but <40 drinks/wk). To reduce alcohol-associated harms they will be randomized in a 1:1 ratio to 2 advices: 1) abstention; 2) moderation (<=7 drinks/wk (females) and <=14 drinks/wk (males)), and avoidance of binge drinking, with preferential consumption of red wine with meals, and consumption spread out throughout the week. Moderate consumption is hypothesized to be non-inferior. No participant will be invited to increase his/her alcohol intake. The primary endpoint will be a global index of all-cause mortality, cardiovascular events, cancer, liver disease, depression, dementia, diabetes, tuberculosis or other major infection or injury. The difficulties for feasibility are significant, but more complex large behavioral trials developed by the principal investigator (PREDIMED and PREDIMED-Plus, two largest nutritional trials conducted in Europe) have attained sufficient compliance in changing not only one aspect of the dietary pattern (alcohol) but many aspects of diet and lifestyle.

Consortium (1)

Project Results (7)

Source: CORDIS, the EU research results database.

Publications (7)
Mediterranean Alcohol-Drinking Pattern and Alcohol-Related Cancer Incidence in the “Seguimiento Universidad de Navarra” (SUN) Cohort
Medical Sciences· 2026DOI
María Barbería-Latasa, Estefanía Toledo, Maira Bes-Rastrollo, María Olmedo, Rafael Pérez-Araluce, Alfredo Gea, Miguel Ángel Martínez-González
Addressing Alcohol Use
New England Journal of Medicine· 2025DOI
Zeniada Vazquez-Ruiz , Miguel Á. Martínez-González
The Mediterranean diet and cardiovascular disease
Cardiovascular Research· 2025DOI
María Barbería-Latasa, Miguel A Martínez-González
The Role of the Mediterranean Diet and Alcohol Consumption in Chronic Liver Disease Prevention: A Narrative Review
Medicina· 2025DOI
María Barbería-Latasa, Diego Martínez-Urbistondo, Miguel A. Martínez-González
American Journal of Clinical Nutrition
The American Journal of Clinical Nutrition· 2024DOI
Miguel A Martínez-González
Effect of the Mediterranean diet in cardiovascular prevention
Revista Española de Cardiología (English Edition)· 2024DOI
Miguel Á. Martínez-González, Aitor Hernández Hernández
European Heart Journal
European Heart Journal· 2024DOI
Inés Domínguez-López; Rosa M Lamuela-Raventós; Cristina Razquin; Camila Arancibia-Riveros; Polina Galkina; Jordi Salas-Salvadó; Ángel M Alonso-Gómez; Montserrat Fitó; Miquel Fiol; José Lapetra; Enrique Gómez-Gracia; José V Sorlí; Miguel Ruiz-Canela; Olga Castañer; Liming Liang; Lluis Serra-Majem; Frank B Hu; Emilio Ros; Miguel Ángel Martínez-González; Ramon Estruch